NCT06990269Phase 2Recruiting

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

Study sponsor: ADARx Pharmaceuticals, Inc.

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2030-02-28Estimated

Enrollment · participants240Estimated

Source updated2026-09-03Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

Posted 2026-04-22 · 1 field changed

Primary completion date

Recorded edit

− Previous value

2027-09-30

+ Updated value

2030-02-28

Check registry source

Posted 2026-01-22 · 2 fields changed

Primary completion date

Recorded edit

− Previous value

2027-09

+ Updated value

2027-09-30

Recruitment status

Recorded edit

− Previous value

Not yet recruiting

+ Updated value

Recruiting

Check registry source